Adverse drug reactions of non-statin antihyperlipidaemic drugs in China from 1989 to 2019: a national database analysis.
Tsui L, Chen L, Ye P, Xu S, Wu SJ, Chen SC, Xie W.
Tsui L, et al.
BMJ Open. 2023 May 30;13(5):e068915. doi: 10.1136/bmjopen-2022-068915.
BMJ Open. 2023.
PMID: 37253501
Free PMC article.
INTERVENTIONS: The non-statin antihyperlipidaemic drugs were divided into three groups: (1) fibrates (fenofibrate, gemfibrozil, bezafibrate, etofylline clofibrate); (2) nicotinic acid and derivatives (niacin, acipimox) and (3) others (probucol, cholestyramine). ...
INTERVENTIONS: The non-statin antihyperlipidaemic drugs were divided into three groups: (1) fibrates (fenofibrate, gemfibrozil, bezafibrate, …